Zentek (TSXV:ZEN) Debt-to-Equity : 0.06 (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Zentek Debt-to-Equity?

Zentek's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.52 Mil. Zentek's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.76 Mil. Zentek's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$22.47 Mil. Zentek's debt to equity for the quarter that ended in Dec. 2023 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Zentek's Debt-to-Equity or its related term are showing as below:

TSXV:ZEN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.05 Max: 0.06
Current: 0.06

During the past 13 years, the highest Debt-to-Equity Ratio of Zentek was 0.06. The lowest was 0.01. And the median was 0.05.

TSXV:ZEN's Debt-to-Equity is ranked better than
77.67% of 703 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs TSXV:ZEN: 0.06

Zentek Debt-to-Equity Historical Data

The historical data trend for Zentek's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek Debt-to-Equity Chart

Zentek Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.05

Zentek Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.06	0.05	0.05	0.05	0.06

Competitive Comparison of Zentek's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Zentek's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zentek's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zentek's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Zentek's Debt-to-Equity falls into.

Zentek Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Zentek's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.127	+	0.485)	/	30.384
	=	0.05

Zentek's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.517	+	0.76)	/	22.472
	=	0.06

Zentek (TSXV:ZEN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Zentek Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Zentek's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zentek (TSXV:ZEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

ZTEK:USA ZAY0:Germany

Address

24 Corporate Ct, Guelph, ON, CAN, N1G 5G5

Website

https://www.zentek.com

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

Executives

Francis Jacques Dubé

Director